Income Taxes - Schedule of Deferred Tax Assets (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Capitalized research and development costs	$ 150,000	$ 150,000
Research and development credits	3,239,000	3,239,000
Stock-based compensation	1,496,000	$ 468,000
Stock options issued in connection with the payment of debt	276,000
Net operating loss carryforwards	36,663,000	$ 35,977,000
Accrued compensation	290,000	59,000
Accrued interest due to related party	70,000	109,000
Other, net	13,000	32,000
Total deferred tax assets	42,197,000	40,034,000
Valuation allowance	$ (42,197,000)	$ (40,034,000)
Net deferred tax assets